CURCUMIN FLEX x2766
Food supplement declared in France, declaration No 2019-10-329
CURCUMIN FLEX x2766 is a food supplement declared in France. Status: retrait du marché annoncé pour le 31 December 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- BIOCYTE
- Status
- Retrait du marché annoncé pour le 31 December 2026
- Form
- Gélule
- Daily dose
- 2 à 4 gélules
- Directions for use
- 2 gélules le matin et 2 gélules le soir, avec un verre d’eau, pendant 1 mois.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants
- Objectives stated by the manufacturer (these are not authorised claims)
- Os, Articulations
Declaration 165818, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 31 December 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Curcuma longa L. | Rhizome | Extrait sec alcoolique | 220 mg |
Additives
E433, Hydroxypropyl Méthyl Cellulose, E330
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.